help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Godil, M. A.
Right arrow Articles by Wilson, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Godil, M. A.
Right arrow Articles by Wilson, T. A.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 11 3964-3967
Copyright © 2000 by The Endocrine Society


Special Articles

Metastatic Congenital Adrenocortical Carcinoma: A Case Report with Tumor Remission at 31/2 Years

Mushtaq A. Godil, Mark P. Atlas, Robert I. Parker, Cedric J. Priebe, Michelle M. Zerah, Philip Kane, James Tsung and Thomas A. Wilson

Departments of Pediatrics (M.A.G., M.P.A., R.I.P., M.M.Z., J.T., T.A.W.), Surgery (C.J.P.), and Pathology (P.K.), State University of New York, Stony Brook, New York 11794-8111

Address all correspondence and requests for reprints to: Thomas A. Wilson, M.D., Department of Pediatrics, State University of New York, Stony Brook, New York 11794-8111. E-mail: twilson{at}mail.som.sunysb.edu

We describe a case of metastasizing congenital adrenocortical carcinoma and a follow-up of 3 1/2 yr. Treatment with surgery and mitotane was associated with multiple complications. The patient was in remission at 3 1/2 yr. Because of the rarity of this condition, we discuss step-by-step problems encountered during management.




This article has been cited by other articles:


Home page
JCOHome page
E. Michalkiewicz, R. Sandrini, B. Figueiredo, E.C.M. Miranda, E. Caran, A.G. Oliveira-Filho, R. Marques, M.A.D. Pianovski, L. Lacerda, L.M. Cristofani, et al.
Clinical and Outcome Characteristics of Children With Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry
J. Clin. Oncol., March 1, 2004; 22(5): 838 - 845.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society